1. Home
  2. SCD vs TKNO Comparison

SCD vs TKNO Comparison

Compare SCD & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCD
    SELLHOLDBUYas of an hour ago
  • TKNO
    SELLHOLDBUYas of 2 days ago
  • Stock Information
  • Founded
  • SCD 2003
  • TKNO 1996
  • Country
  • SCD United States
  • TKNO United States
  • Employees
  • SCD N/A
  • TKNO N/A
  • Industry
  • SCD Trusts Except Educational Religious and Charitable
  • TKNO Medicinal Chemicals and Botanical Products
  • Sector
  • SCD Finance
  • TKNO Health Care
  • Exchange
  • SCD Nasdaq
  • TKNO Nasdaq
  • Market Cap
  • SCD N/A
  • TKNO 390.7M
  • IPO Year
  • SCD N/A
  • TKNO 2021
  • Fundamental
  • Price
  • SCD $16.65
  • TKNO $8.08
  • Analyst Decision
  • SCD
  • TKNO Buy
  • Analyst Count
  • SCD 0
  • TKNO 2
  • Target Price
  • SCD N/A
  • TKNO $5.00
  • AVG Volume (30 Days)
  • SCD 62.6K
  • TKNO 294.4K
  • Earning Date
  • SCD 01-01-0001
  • TKNO 11-07-2024
  • Dividend Yield
  • SCD 9.63%
  • TKNO N/A
  • EPS Growth
  • SCD N/A
  • TKNO N/A
  • EPS
  • SCD N/A
  • TKNO N/A
  • Revenue
  • SCD N/A
  • TKNO $36,347,000.00
  • Revenue This Year
  • SCD N/A
  • TKNO $3.47
  • Revenue Next Year
  • SCD N/A
  • TKNO $12.07
  • P/E Ratio
  • SCD N/A
  • TKNO N/A
  • Revenue Growth
  • SCD N/A
  • TKNO N/A
  • 52 Week Low
  • SCD $11.33
  • TKNO $1.16
  • 52 Week High
  • SCD $15.87
  • TKNO $9.72
  • Technical
  • Relative Strength Index (RSI)
  • SCD 36.48
  • TKNO 52.57
  • Support Level
  • SCD $16.80
  • TKNO $7.89
  • Resistance Level
  • SCD $17.35
  • TKNO $9.43
  • Average True Range (ATR)
  • SCD 0.38
  • TKNO 0.88
  • MACD
  • SCD -0.03
  • TKNO -0.01
  • Stochastic Oscillator
  • SCD 22.73
  • TKNO 51.47

Stock Price Comparison Chart: SCD vs TKNO

SCD
TKNO
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250246810121416182022242628SCD VS TKNO

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use